{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:57:38Z","timestamp":1790805458972,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Sanidad y Consumo"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2018-00020723"],"award-info":[{"award-number":["2018-00020723"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Catalan Health Agency","award":["2017SGR1432"],"award-info":[{"award-number":["2017SGR1432"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI18\/01061"],"award-info":[{"award-number":["FIS PI18\/01061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RH041828"],"award-info":[{"award-number":["RH041828"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cmi.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:13:36Z","timestamp":1562613216000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection"],"prefix":"10.1016","volume":"26","author":[{"given":"D.","family":"Viasus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Puerta-Alcalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Su\u00e1rez-Lled\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Rodr\u00edguez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Morata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Feh\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chumbita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Moreno-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fern\u00e1ndez-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guti\u00e9rrez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mensa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.07.002_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of bacteraemia and mortality in patients with haematological malignancies","volume":"12","author":"N\u00f8rgaard","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.07.002_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes","volume":"66","author":"Gudiol","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.07.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0199531","article-title":"Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance","volume":"13","author":"Garcia-Vidal","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.07.002_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2019.07.002_bib5","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2019.07.002_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IPC.0b013e31822c8f36","article-title":"Highlights from clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: an update by the infectious diseases society of America","volume":"19","author":"Freifeld","year":"2011","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.cmi.2019.07.002_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","article-title":"P.\u00a0aeruginosa bloodstream infections among hematological patients: an old or new question?","volume":"91","author":"Cattaneo","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cmi.2019.07.002_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2010.036640","article-title":"Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies","volume":"96","author":"Trecarichi","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2019.07.002_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","article-title":"Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome","volume":"88","author":"Tofas","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.002_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diagmicrobio.2009.02.008","article-title":"Factors associated with mortality in bacteremic patients with hematologic malignancies","volume":"64","author":"Tumbarello","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.002_bib11","first-page":"1356","article-title":"Current time-to-positivity of blood cultures in the febrile neutropenia: a tool to be used in stewardship de-escalation strategies","volume":"46","author":"Puerta-Alcalde","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.07.002_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jac\/dkx521","article-title":"A\u00a0multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae","volume":"73","author":"Boutal","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.07.002_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/dku476","article-title":"Evaluation of the eazyplex\u00ae SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals","volume":"70","author":"Garc\u00eda-Fern\u00e1ndez","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.07.002_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijantimicag.2015.06.002","article-title":"Rapid detection of \u03b2-lactamases directly from positive blood cultures using a loop-mediated isothermal amplification (LAMP)-based assay","volume":"46","author":"Zboromyrska","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2019.07.002_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10096-015-2566-8","article-title":"Staphylococcus aureus bacteremic pneumonia","volume":"35","author":"De la Calle","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.002_bib16","series-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2008"},{"key":"10.1016\/j.cmi.2019.07.002_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12879-017-2597-0","article-title":"Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.002_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.07.002_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajic.2009.02.003","article-title":"Previous ciprofloxacin exposure is associated with resistance to \u03b2-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates","volume":"37","author":"L\u00f3pez-Dupla","year":"2009","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2019.07.002_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/379709","article-title":"Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991\u20132000","volume":"37","author":"Zervos","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.07.002_bib21","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/jac\/dkv228","article-title":"In\u00a0vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure","volume":"70","author":"Sol\u00e9","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.07.002_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkz147","article-title":"Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology","author":"del Barrio-Tofi\u00f1o","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930391X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930391X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:55Z","timestamp":1761117835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1930391X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1198743X1930391X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.07.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}